Aulos Bioscience

Aulos Bioscience is an immuno-oncology company revolutionizing cancer patient care through best-in-class IL-2 therapeutics computationally designed to exquisitely direct patients own immune systems toward killing tumor cells. Matching world-class machine learning from founder and partner Biolojic Design with an in-depth understanding of the immune system, Aulos initial clinical candidate, AU-007, has been designed to harness the power of a patients own IL-2 to induce tumor killing while limiting the immunosuppression and toxicities typically associated with this validated class of therapeutics. AU-007 has the potential to become a best-in-class treatment for solid tumors. The company was founded by Biolojic Design and...

Immuno oncology ,oncology,monoclonal antibodies,and cancer research

Aulos bioscience operates in the Biotechnology research industry.

Aulos bioscience's revenue is 1m - 10m

Aulos bioscience has 11 - 50 employees.